A Canadian CBD cosmetics, supplements and medical cannabis product company has received an important license from the government of Colombia, where its grow operations are located.
The advent of a strategic patent has put formulation specialist Biomedican on course to fundamentally alter the cannabinoid supply picture, the company claims. In addition, a Mexican court ruling has opened up opportunities south of the border.
A new extraction facility is about to come online in Florida, while at the same time a California company is planning a launch of CBD products in Brazil and Uruguay.
